Tag: Editas
Editas Medicine is not a buy
DraftKings Inc: "They are in a battle, a pure battle to try to get market share and right now, there is no sign that the battle is over. ... I do thin [...]
Editas, Intellia: After Massive Promote Off, Is it Time To Purchase Gene Modifying Shares?
Our indicative theme of Gene Modifying shares is down by about 24% year-to-date, in comparison with the S&P 500 which has remained nearly flat [...]
Editas (EDIT) to Report This fall Earnings: What's within the Playing cards?
We anticipate traders to concentrate on the progress of Editas Drugs, Inc. EDIT with its lead pipeline candidate EDIT-101 and different pipeline ca [...]
CRISPR, Editas, Intellia: Gene Modifying Shares To Play The Subsequent Revolution In Medication
Gene enhancing has emerged as a promising biotech theme. The know-how is used to insert, edit, or d [...]
8 / 8 POSTS